Glycopyrrolate is used for: In Anesthesia:; • As a pre-operative antimuscarinic agent to reduce salivary; tracheobronchial and pharyngeal sections and to reduce the acidity of the gastric contents; • As a pre-operative or intra-operative antimuscarinic to attenuate or prevent intra-operative bradycardia with the use of suxamethonium or due to cardiac vagal reflexes; • To protect against the peripheral muscarinic actions of anticholinesterases such as neostigmine and pyridostigmine; used to reverse residual neuromuscular blockade produced by non- depolarising muscle relaxants; In Peptic Ulcer: For use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or when oral medication is not tolerated; Hyperhidrosis; Sialorrhea; Cerebral palsy.
Recorded in the NepalDoc medicine catalog for Glycopyrrolate.
Glycopyrrolate Injection is an anticholinergic indicated: in anesthesia (adult and pediatric patients) for reduction of salivary, tracheobronchial, and pharyngeal secretions, reduction of volume and acidity of gastric secretions, and blockade of cardiac inhibitory reflexes during induction of anesthesia and intubation. intraoperatively to counteract surgically or drug-induced or vagal reflex-associated arrhythmias.
From the U.S. FDA-approved label for Glycopyrrolate. Full label: DailyMed.
Glycopyrrolate Injection is an anticholinergic indicated: in anesthesia (adult and pediatric patients) for reduction of salivary, tracheobronchial, and pharyngeal secretions, reduction of volume and acidity of gastric secretions, and blockade of cardiac inhibitory reflexes during induction of anesthesia and intubation. intraoperatively to counteract surgically or drug-induced or vagal reflex-associated arrhythmias. for protection against peripheral muscarinic effects of cholinergic agents. in peptic ulcer (adults) To reduce symptoms of a peptic ulcer as an adjunct to treatment of peptic ulcer when rapid anticholinergic effect is desired or oral medication is not tolerated.
From the U.S. FDA-approved label for Glycopyrrolate. Full label: DailyMed.
Glycopyrrolate injection may be administered intramuscularly (IM), or intravenously (IV) without dilution, in the following indications.
Directions from the U.S. FDA-approved label for Glycopyrrolate — your doctor or pharmacist may advise differently.
Glycopyrrolate injection is contraindicated in: patients with known hypersensitivity to glycopyrrolate injection or any of its inactive ingredients.
Excerpt from the U.S. FDA-approved label for Glycopyrrolate. Talk to a pharmacist or doctor before use.
Precipitation of Acute Glaucoma: May cause mydriasis and increase intraocular pressure in patients with glaucoma. Advise patients with glaucoma to promptly seek medical care if they experience symptoms of acute angle closure glaucoma. Drowsiness or Blurred Vision: May cause drowsiness or blurred vision. Advise patients not to drive or perform hazardous work until resolved. Heat Prostration: Advise patients to avoid exertion and high environmental temperatures after receiving glycopyrrolate injection. Intestinal Obstruction: Diarrhea may be an early symptom of incomplete intestinal obstruction.
Warnings and precautions excerpt from the U.S. FDA-approved label for Glycopyrrolate — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions were identified in clinical studies or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Adverse reactions to anticholinergics include xerostomia (dry mouth); urinary hesitancy and retention;
Excerpt from the U.S. FDA-approved label for Glycopyrrolate — not a complete list. Talk to a pharmacist or doctor about side effects.
2 brands · 2 makers in the NepalDoc catalog — see the full Glycopyrrolate guide →
Storage Conditions Store at 20° to 25°C (68° to 77°F);
Storage information from the U.S. FDA-approved label for Glycopyrrolate.
What is Pyrolate?
Pyrolate 0.2mg Injection is a Glycopyrrolate medicine made by Neon Laboratories Ltd. It comes as 0.2mg Injection.
What is Pyrolate used for?
Glycopyrrolate is used for In Anesthesia:, • As a pre-operative antimuscarinic agent to reduce salivary, tracheobronchial and pharyngeal sections and to reduce the acidity of the gastric contents, • As a pre-operative or intra-operative antimuscarinic to attenuate or prevent intra-operative bradycardia with the use of suxamethonium or due to cardiac vagal reflexes, • To protect against the peripheral muscarinic actions of anticholinesterases such as neostigmine and pyridostigmine, used to reverse residual neuromuscular blockade produced by non- depolarising muscle relaxants, In Peptic Ulcer: For use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or when oral medication is not tolerated, Hyperhidrosis, Sialorrhea, Cerebral palsy.
What is the generic name of Pyrolate?
The generic name of Pyrolate is Glycopyrrolate.
Which brands of Glycopyrrolate are available in Nepal?
2 brands of Glycopyrrolate are listed in the NepalDoc catalog, from 2 makers — including Glyco 4mg Injection.
What are the side effects of Glycopyrrolate?
The following adverse reactions were identified in clinical studies or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
